Mice lacking the mitochondrial exonuclease MGME1 develop inflammatory kidney disease with glomerular dysfunction

Dusanka Milenkovic1, Adrián Sanz-Moreno2, Julia Calzada-Wack2

  • 1Max Planck Institute for Biology of Ageing, Cologne, Germany.

Plos Genetics
|May 9, 2022
PubMed

Insights

Mitochondrial genome and maintenance exonuclease 1 (MGME1) loss causes new mtDNA fragments and impairs replication. Mgme1 knockout mice develop age-related multisystem disease, including kidney inflammation and nephropathy.

Area of Science:

  • Mitochondrial biology
  • Genetics
  • Pathophysiology

Background:

  • Mitochondrial DNA (mtDNA) maintenance disorders arise from nuclear gene mutations, causing varied syndromes.
  • Loss-of-function mutations in MGME1 lead to mtDNA deletions/depletion, resulting in adult-onset multisystem mitochondrial disease.

Purpose of the Study:

  • To investigate the in vivo function of MGME1.
  • To characterize the pathophysiology of MGME1-associated mitochondrial disease using a knockout mouse model.

Main Methods:

  • Extensive phenotyping of aging Mgme1 knockout mice.
  • Analysis of de novo formation and degradation of linear deleted mtDNA fragments.
  • Assessment of age-related phenotypes including weight, vision, and kidney function.

Main Results:

  • Loss of MGME1 causes de novo formation and degradation of linear deleted mtDNA fragments.
  • MGME1 is critical for completing mtDNA replication, not degrading linear fragments.
  • Mgme1 knockout mice exhibit progressive weight loss, cataracts, retinopathy, and severe chronic progressive nephropathy with kidney inflammation.

Conclusions:

  • Defective mtDNA replication due to MGME1 deficiency triggers an immune response.
  • This immune response contributes to age-associated kidney pathology, linking faulty mtDNA synthesis to inflammatory disease.